“Dyspepsia”的搜索结果，显示 301-310 项，共有 11007 项

1. 血液科- 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz., Rochester, Minn. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

2. 血液科- 临床试验- 妙佑医疗国际

   DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel ...

3. 临床基因组学科- 临床试验- 妙佑医疗国际

   妙佑医疗国际临床基因组学科采用基因组检测来了解一个人的DNA，从而帮助预测、预防、诊断和治疗疾病。

4. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis. A ...

5. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to compare epcoritamab to standard practice (observation) for the treatment of patients with B-cell lymphomas who are not in ...

6. 肾病和高血压- 临床试验- 妙佑医疗国际

   Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

8. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...